Evidence map›Paper›PMID 25208875›Full record

ArticlePharmaceutical research2015

Stimulation and suppression of innate immune function by American ginseng polysaccharides: biological relevance and identification of bioactives.

Chike G Azike, Paul A Charpentier, Edmund M K Lui

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Food science & nutrition · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Molecules (Basel, Switzerland) · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chike G AzikeOntario Ginseng Innovation and Research Consortium, University of Western Ontario, London, ON, N6A 5C1, Canada, chikeazike@yahoo.com.
Paul A Charpentier
Edmund M K Lui
Western University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolysaccharides constituting about 10% by weight of ginseng root are known to stimulate the immune system but have recently been shown to also suppress induced proinflammatory responses. Our study aims to determine whether American ginseng root polysaccharides (AGRPS) stimulates basal innate immune function and at the same time can suppress response to lipopolysaccharide (LPS) induced proinflammatory response. An in vitro mechanistic study was used to identify the bioactive fraction(s) responsible for AGRPS immunomodulatory effects.

methodsThe ex vivo and in vivo immunomodulatory effects after oral administration of AGRPS extract was studied in adult rats by measuring cultured alveolar macrophage production of NO and changes of plasma cytokine level, modification of LPS proinflammatory immune response by AGRPS extract was also examined. To identify the bioactive fraction(s) responsible for AGRPS extract immunomodulatory effects, the immunobioactivities of the extract fractions (isolated by ion exchange and size exclusion chromatography) was investigated in an in vitro mechanistic study.

resultsCulture of alveolar macrophages obtained from AGRPS extract treated rats resulted in an increase of ex vivo production of NO and also reduced alveolar macrophage responsiveness to ex vivo LPS challenge. Oral treatment with AGRPS extract elevated plasma TNF-α concentration in vivo. This treatment also suppressed LPS induced elevation of plasma TNF-α in vivo. AGRPS extract immunostimulatory and immunosuppressive effects were mediated primarily by acid PS and its species with molecular weights ≥ 100 kDa and 50-100 kDa.

conclusionAGRPS extract exerted immunostimulation and suppressed LPS immune response under basal and LPS induced proinflammatory conditions respectively.

Indexed as

PanaxAdjuvants, ImmunologicAdministration, OralAnimalsCell LineCytokinesDose-Response Relationship, DrugImmunity, InnateImmunosuppressive AgentsInflammation MediatorsLipopolysaccharidesMacrophages, AlveolarMaleMiceNitric OxidePhytotherapyAdjuvants, ImmunologicCytokinesImmunosuppressive AgentsInflammation MediatorsLipopolysaccharidesNitric OxidePolysaccharides

Identifiers

PMID25208875
OpenAlexW2041543868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.